Levorotatory Chiral Peptide HBSP Ameliorates Renal Ischemia Reperfusion Injury in a Murine Model

L. Li,C. Yang,T. Zhu
DOI: https://doi.org/10.1097/00007890-201407151-01143
2014-01-01
Transplantation
Abstract:Objective: To investigate the protective effect of levorotatory chiral peptide HBSP against renal ischemia reperfusion injury in mice. Methods: 60 male BALB/C mice (20-25g) were randomly divided into two groups: ischemia reperfusion group (IR group) and ischemia reperfusion with HBSP treatment group (IR + HBSP group). Blood and kidney samples were collected 6h, 12h, 24h, 48h, 5d, 7d after surgery respectively. Serum creatinine, urea nitrogen and renal pathological injury were detected, as well as the expression of TNF-α and IL-6 by RT-PCR. Apoptosis of tubular epithelium was examined by TUNEL assay and IHC stainging of caspase-3. Results: Both serum creatinine and urea nitrogen were decreased in IR+HBSP group from 6 h to 48 h after surgery accompanied with mild histological damage, and less TUNEL and caspase-3 positive cells.Figure: No Caption available.Figure: No Caption available.The expression level of IL-6 and TNF-α in IR+HBSP group was also down-regulated. Conclusion: HBSP, a recently syntheticed levorotatory chiral polypeptide, attenuates renal ischemia reperfusion injury. The protective effect is mediated by inhibition of tubular epithelium apoptosis and inflammation.
What problem does this paper attempt to address?